Resources
Did you mean
U.S. Patent and Trademark Office (1,401 results)
- sort by:
- Relevance
- Date
- Popularity
- Pacific Sands' EcoOne(R) Logo Receives Trademark Registration With U.S. Patent and Trademark Office.
- M2 PRESSWIRE-24 August 2006-U.S. Equity News: Pacific Sands' EcoOneR Logo Receives Trademark Registration With U.S. Patent and Trademark OfficeC1994-2006 M2 COMMUNICATIONS LTD RDATE:24082006 City of Industry, CA - Pacific Sands, Inc. (OTCBB: PFSD) is pleased to announce that its EcoOne logo...
- Research articles 2006-08-24
- Filling of notice of a security interest in a trademark with the U.S. Patent and Trademark office insufficient to perfect such security interest
- Filing of notice of a security interest in a trademark with the U.S. Patent and Trademark Office insufficient to perfect such security interest
- Research articles 2001-11-01
- Vicor Announces Reissue of Reset Patent by U.S. Patent Office
- ANDOVER, Mass.--BUSINESS WIRE--Feb. 17, 1999--Vicor Corporation ("Vicor") today announced that on February 16, 1999, the United States Patent and Trademark Office issued U.S. patent RE36,098 (the "Reissue Patent") as a reissue of U.S. Patent 4,441,146 (the "Reset Patent"). The Reissue Patent includes original claims 1 through 5 of the Reset...
- Research articles 1999-02-17
- Dyax Corp. Issued Seventh U.S. Patent in Its Phage Display Patent Portfolio
- CAMBRIDGE, Mass. -- Dyax Corp. (Nasdaq:DYAX) announced today that the United States Patent and Trademark office issued U.S. Patent No. 7,208,293, Dyax's seventh U.S. patent covering its proprietary protein display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting binding proteins, such as antibodies,...
- Research articles 2007-05-01
- Dyax Corp. Issued Sixth U.S. Patent in Its Phage Display Patent Portfolio
- CAMBRIDGE, Mass. -- Dyax Corp. (Nasdaq: DYAX) announced today that the United States Patent and Trademark office issued U.S. Patent No. 7,118,879, Dyax's sixth U.S. patent covering its proprietary phage display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting antibodies physically associated with...
- Research articles 2006-10-11
- Dyax Corp. Issued Fifth U.S. Patent in Its Phage Display Patent Portfolio
- CAMBRIDGE, Mass. -- Dyax Corp. (Nasdaq:DYAX) announced today that the United States Patent and Trademark office issued U.S. Patent No. 6,979,538, Dyax's fifth U.S. patent covering its proprietary Phage Display technology. This new patent provides Dyax with additional patent claims that cover methods for displaying antibodies on filamentous bacteriophage. In...
- Research articles 2006-01-10
- U.S. Patent Awarded to One Voice Technologies; One Voice Also Receives Notice of Allowance for Second Patent
- Business Editors and High-Tech Writers SAN DIEGO--BUSINESS WIRE--Aug. 22, 2002 One Voice Technologies Inc. (OTCBB:ONEV), developer of 4th Generation voice solutions for the wireless, Telematics, TV/Internet appliance and Interactive Multimedia markets today announced that it has been awarded a patent by the U.S. Patent and Trademark Office. ...
- Research articles 2002-08-22
- Somatix Receives U.S. Patent Covering Method For Treating Glioma
- ALAMEDA, Calif.--BUSINESS WIRE--June 27, 1996--Somatix Therapy Corp. (NASDAQ: SOMA) announced today that a Patent covering a method for treating glioma has been issued by the United States Patent and Trademark Office.The U.S. Patent No: 5,529,774, which is exclusively licensed to the company, was originally filed by the University of California...
- Research articles 1996-06-27
- U.S. Patent and Trademark Office changing to electronic format
- The U.S. Patent and Trademark Office USPTO is changing to an electronic format for the electronic certified copies it supplies of U.S. patent applications as filed, and U.S. patent-related file wrappers and contents.
- Research articles 2004-08-17
- Pacific Sands' EcoOne(R) Logo Receives Trademark Registration With U.S. Patent and Trademark Office
- Pacific Sands, Inc. (OTCBB: PFSD) is pleased to announce that its EcoOne® logo has received registered trademark status with the U.S. Patent and Trademark Office (registration number 3116167). After nearly two years of submissions, re-submissions, amendments, and negotiation, the increasingly popular EcoOne® consumer brand is now protected by law. ...
- Research articles 2006-08-15
- U.S. Patent Office Upholds StemCells, Inc.'s Patents in Reexamination Decisions
- PALO ALTO, Calif. -- StemCells, Inc. (NASDAQ:STEM) announced today that the U.S. Patent and Trademark Office PTO has upheld two of the Company's neural stem cell patents, with only minor amendments, thereby rejecting the arguments raised by Neuralstem, Inc. in its reexamination petitions of last year. The upheld patents,...
- Research articles 2008-04-15
- U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
- LAS VEGAS -- CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that the U.S. Patent and Trademark Office allowed CVBT's patent application entitled, "Method of Producing Biologically Active Human Acidic Fibroblast Growth Factor and its Use in Promoting Angiogenesis." This patent describes the technology to produce human Acidic Fibroblast Growth Factor, also...
- Research articles 2007-01-09
- Crocs, Inc. Awarded Multiple Patents for Utility and Design of Footwear Products; Company Files Actions in the U.S. International Trade Commission and U.S. District Court Against 11 Companies to Protect Intellectual Property
- NIWOT, Colo. -- Crocs, Inc. (NASDAQ: CROX) today announced it has received four patents covering various aspects of its footwear. The patents, which cover utility aspects applicable to a number of its footwear models and design elements of its BeachTM, Cayman, NileTM and HighlandTM models, were recently issued by the...
- Research articles 2006-04-03
- U.S. PATENT OFFICE REJECTS UNOCAL'S '393 PATENT CLAIMS
- U.S. oil companies caught the first break in their battle against Unocal's RFG patents when the U.S. Patent and Trademark Office PTO announced Tuesday it was rejecting Unocal's '393 patent. The decision comes 10 months after the PTO agreed to re-exam U.S. oil companies caught the first break...
- Research articles 2002-02-25
- U.S. PATENT OFFICE TO RE-EXAMINE A SECOND UNOCAL GASOLINE PATENT
- Unocal Corp.'s '126 gasoline patent, one of the company's five highly debated RFG patents, will face re-examination by the U.S. Patent and Trademark Office PTO. The '126 patent will be re- examined because of a "substantial new question of paten Unocal Corp.'s '126 gasoline patent, one of the...
- Research articles 2002-02-04
- Notice has been given that the U.S. Patent & Trademark Office (USPTO). (Related News in Brief).
- Notice has been given that the U.S. Patent & Trademark Office USPTO will discontinue the publication of the print version of the "Official Gazette ... Notice has been given that the U.S. Patent & Trademark Office USPTO will discontinue the publication of the print version of...
- Research articles 2002-07-01
- ARDENT SOFTWARE: U.S. Patent and Trademark Office selects Ardent Software's Quality Manager.
- M2 PRESSWIRE-19 May 1999-ARDENT SOFTWARE: U.S. Patent and Trademark Office selects Ardent Software's Quality Manager C1994-99 M2 COMMUNICATIONS LTD RDATE:180599 * Ardent Software Ensures Quality of Patent and Trademark Data WESTBORO, Mass. -- Ardent Software, Inc. (Nasdaq: ARDT), a...
- Research articles 1999-05-19
- U.S. Patent and Trademark Office Grants Artes Medical's Request for Reexamination of Competitor's Patent
- SAN DIEGO -- Artes Medical Inc., a privately-held specialty pharmaceutical and medical device company, announced today that the U.S. Patent and Trademark Office USPTO has granted its request for reexamination of the Aventis patent that covers injectable skin fillers using poly-lactic-acid PLA microspheres, marketed in the U.S. under the SculptraTM...
- Research articles 2005-01-06
- U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
- NEW YORK -- Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued a communication notifying the company that it will confirm the patentability of the claims of Pfizer's '893 basic patent for Lipitor. The Patent Office had conducted a re-examination of the '893 patent in response...
- Research articles 2008-04-30
- U.S. Patent & Trademark Office Rejects Claims in Synopsys Patent, Magma Announces
- SANTA CLARA, Calif. -- The U.S. Patent and Trademark Office today rejected all the claims in Synopsys Inc.'s patent number 6,378,114 (the '114 patent), calling into question the validity of the patent, MagmaR Design Automation Inc. (Nasdaq:LAVA) said in a statement today. The validity of the '114 patent has been...
- Research articles 2006-08-17
- << Previous
- page 1 of 43
- Next >>
